• 1. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 2. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 3. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 4. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 5. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877

Research Brief on 6-Hydrazinylpyridine-2-Carbonitrile (CAS: 1339085-85-6) in Chemical Biology and Pharmaceutical Applications

6-Hydrazinylpyridine-2-carbonitrile (CAS: 1339085-85-6) is a versatile chemical intermediate that has garnered significant attention in recent years due to its potential applications in medicinal chemistry and drug discovery. This heterocyclic compound, characterized by a pyridine core functionalized with a hydrazinyl group and a nitrile moiety, serves as a key building block for the synthesis of pharmacologically active molecules. Recent studies have explored its utility in the development of kinase inhibitors, antimicrobial agents, and fluorescent probes, positioning it as a valuable scaffold in chemical biology research.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the efficacy of 6-hydrazinylpyridine-2-carbonitrile derivatives as selective inhibitors of cyclin-dependent kinases (CDKs). The research team utilized structure-activity relationship (SAR) analysis to optimize the compound's binding affinity, achieving nanomolar potency against CDK2 while maintaining excellent selectivity over other kinase family members. Molecular docking studies revealed that the hydrazinyl group forms critical hydrogen bonds with the kinase hinge region, while the nitrile moiety contributes to hydrophobic interactions in the ATP-binding pocket.

In antimicrobial research, derivatives of 6-hydrazinylpyridine-2-carbonitrile have shown promising activity against drug-resistant bacterial strains. A recent publication in Bioorganic Chemistry (2024) reported novel hydrazone derivatives exhibiting potent inhibition of Escherichia coli DNA gyrase, with minimum inhibitory concentrations (MICs) comparable to existing fluoroquinolone antibiotics. The electron-withdrawing nitrile group was found to enhance membrane permeability, while the hydrazinyl functionality enabled the formation of Schiff bases with bacterial target proteins.

The compound's utility extends to diagnostic applications as well. Researchers at MIT developed a series of fluorescent probes based on 6-hydrazinylpyridine-2-carbonitrile for real-time imaging of reactive oxygen species (ROS) in cellular systems (Nature Chemical Biology, 2023). The probes demonstrated exceptional sensitivity and selectivity for hydroxyl radicals, with the hydrazinyl group serving as the reactive site for ROS detection and the pyridine-nitrogen providing stabilization through intramolecular hydrogen bonding.

From a synthetic chemistry perspective, 6-hydrazinylpyridine-2-carbonitrile offers several advantages. Its modular structure allows for diverse functionalization at multiple positions, enabling rapid generation of compound libraries for high-throughput screening. Recent advances in flow chemistry have improved the scalability of its synthesis, with a 2024 Organic Process Research & Development publication reporting a continuous-flow protocol that achieves 85% yield with excellent purity (>99%) at kilogram scale.

Despite these promising developments, challenges remain in the clinical translation of 6-hydrazinylpyridine-2-carbonitrile derivatives. Pharmacokinetic studies indicate that some analogs exhibit limited oral bioavailability due to rapid hepatic metabolism of the hydrazine moiety. Current research efforts are focused on prodrug strategies and structural modifications to improve metabolic stability while retaining biological activity.

In conclusion, 6-hydrazinylpyridine-2-carbonitrile (CAS: 1339085-85-6) represents a privileged scaffold with diverse applications in drug discovery and chemical biology. Its unique combination of hydrogen bond donor/acceptor properties and synthetic versatility continues to inspire innovative research across multiple therapeutic areas. Future directions include the development of covalent inhibitors leveraging the reactive hydrazine group and the exploration of its metal-chelating properties for catalytic applications.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)